147 / 815
With new techniques, carcinogenesis needs to be monitored; there might also be
unsuspected regions of high dose within the patient
ICRU: “… The volume within the patient excluding any delineated OAR and the
CTV(s) should be identified as the “remaining volume at risk” (RVR)”
Volumes in ICRU78 and ICRU83